| Faculty | Relationship Identified With: |
| Dr. Aakash Desai | Nothing to disclose |
| Nicolas Girard MD, PhD | Consultant/Research Funding to Institute: Roche, AstraZeneca, Amgen; Research Funding to Institute: PharmaMar |
| Ravi Kalhan, MD, MS | Consultant: CVS Caremark, Boehringer Ingelheim Consultant/Speaker: AstraZeneca, GlaxoSmithKline |
| Antonio Passaro MD, PhD | Consulting or Advisory Role: Roche/Genentech, Bristol Myers Squibb, AstraZeneca, MSD Oncology, Pfizer, Boehringer Ingelheim, Johnson & Johnson/Janssen, Novartis, Lilly Speakers’ Bureau: AstraZeneca, Johnson & Johnson/Janssen, Boehringer Ingelheim |
| Sandip P Patel, MD | Scientific Advisory: Amgen, AstraZeneca, Bristol-Myers Squibb, Certis, Eli Lilly, Jazz, Genentech, Illumina , Merck, Pfizer, Rakuten, Tempus; Research Funding: Amgen, AstraZeneca/MedImmune, Bristol-Myers Squibb, Eli Lilly, Fate Therapeutics, Gilead, Iovance, Merck, Pfizer, Roche/Genentech, SQZ Biotechnologies |
| Christina Thornton, MD PhD FRCPC | Nothing to disclose |
| Shannon Turvey | Speaker, Advisory Board Member, Consultant: Gilead; Advisory Board Member: Vily |
| Jason Weatherald, MD | Advisory board participant: Acceleron; Advisory board participant, speaker’s bureau, research grant recipient: Janssen/Actelion; Shareholder: Precision Lung Consultants & Diagnostics; Clinical Trial investigator: Merck |
All relevant financial relationships with ineligible companies for this educational content have been mitigated.